Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1008402-47-8
1644231-07-1
756525-98-1
2055040-99-6
2110449-02-8
2100306-51-0
2183440-38-0 | Methyltetrazine-PEG12-t-butyl ester | AA019EEZ | MFCD31580140
449211-78-3 | (4-(2H-1,2,3-Triazol-2-yl)phenyl)methanol | AA019EIK | MFCD30185865
84131-04-4 | 2-(2-(2-(benzyloxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | AA019ELO | MFCD31555345
908600-73-7 | 1H-INDOLE-5-CARBOXYLIC ACID,6-FLUORO | AA019EOU | MFCD12924426
2096338-21-3 | 3-Fluoro-5-(5-chloro-2-methylphenylcarbamoyl)benzeneboronic acid | AA019ES2 | MFCD20040134
136604-60-9 | 2-(4-methyl-1,3-thiazol-5-yl)ethan-1-amine dihydrochloride | AA019EVB | MFCD18071277
443647-21-0 | (4-Bromo-naphthalen-1-yloxy)-acetic acid methyl ester | AA019EXQ | MFCD03129267
127910-32-1 | (E)-(4-Amino-5-ethoxy-2-methyl-5-oxopent-2-en-1-yl)phosphonic acid | AA019FQM | MFCD00882474
62828-00-6 | 1-Methylpiperazine-2,6-dione | AA019G6Z | MFCD19219203
325721-18-4 | 3-[(4-ethoxyphenyl)sulfamoyl]benzoic acid | AA019GIL | MFCD01417116